Pharmacogenetic Analyses of a Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma With Fluorouracil and Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

2009123 citationsReviewbronze Open Access

Authors

Eray Goekkurt · Universität Hamburg

Salah‐Eddin Al‐Batran · Universität Hamburg

Jörg T. Hartmann · Universität Hamburg

U. Mogck · Universität Hamburg

Gunter Schuch · Universität Hamburg

Michael Krämer · Universität Hamburg

E. Jaeger ·

Abstract

These findings underline the hypothesis that germ-line polymorphisms may play an important role in individualizing chemotherapy in AGC and deserve further prospective evaluation in AGC patients.

Topics & Keywords

Lung Cancer Treatments and Mutations Gastric Cancer Management and Outcomes Colorectal Cancer Treatments and Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 27, Issue 17, pp. 2863-2873

DOI: 10.1200/jco.2008.19.1718

Field-Weighted Citation Impact: 7.45